APP

amyloid beta (A4) precursor protein

APP; amyloid beta (A4) precursor protein; AAA; AD1; PN2; ABPP; APPI; CVAP; ABETA; PN-II; CTFgamma; amyloid beta A4 protein; preA4; protease nexin-II; peptidase nexin-II; beta-amyloid peptide; alzheimer disease amyloid protein; cerebral vascular amyloid peptide;

BACE1

beta-site APP-cleaving enzyme 1

BACE1; beta-site APP-cleaving enzyme 1; ASP2; BACE; HSPC104; beta-secretase 1; asp 2; memapsin-2; APP beta-secretase; aspartyl protease 2; beta-site APP cleaving enzyme 1; beta-secretase 1 precursor variant 1; transmembrane aspartic proteinase Asp2; membrane-associated aspartic protease 2; beta-site amyloid beta A4 precursor protein-cleaving enzyme;

Bace2

beta-site APP-cleaving enzyme 2

BACE2; beta-site APP-cleaving enzyme 2; ASP1; BAE2; DRAP; AEPLC; ALP56; ASP21; CDA13; CEAP1; beta-secretase 2; memapsin-1; theta-secretase; aspartyl protease 1; 56 kDa aspartic-like protease; Down syndrome region aspartic protease; transmembrane aspartic proteinase Asp1; membrane-associated aspartic protease 1; beta-site amyloid beta A4 precursor protein-cleaving enzyme 2;

CAPG

capping protein (actin filament), gelsolin-like

CAPG; capping protein (actin filament), gelsolin-like; AFCP; macrophage-capping protein; macrophage capping protein; MCP; Actin capping protein GCAP39; Actin regulatory protein CAP G; Capping protein (actin filament) gelsolin like; Capping protein gelsolin like; gCap39; Gelsolin like capping protein; mbh1; Myc basic motif homolog 1; OTTHUMP00000203056; OTTHUMP00000203057; OTTHUMP00000203058; OTTHUMP00000203059; OTTHUMP00000203060; OTTHUMP00000203063; gelsolin-like capping protein; actin regulatory protein CAP-G; actin-regulatory protein C;

CAPZA1

capping protein (actin filament) muscle Z-line, alpha 1

CAPZA1; capping protein (actin filament) muscle Z-line, alpha 1; CAPZ; CAZ1; CAPPA1;

ERCC1

excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)

ERCC1; excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence); DNA excision repair protein ERCC-1; RAD10; UV20; COFS4;

GSTK1

glutathione S-transferase kappa 1

GSTK1; glutathione S-transferase kappa 1; GST13; GST class-kappa; glutathione S-transferase k1; glutathione S-transferase subunit 13 homolog; GST; hGSTK1; GSTK1-1; GST13-13; GST 13-13;

IFNK

interferon, kappa

IFNK; interferon, kappa; interferon kappa; IFN kappa; IFN-kappa; interferon-like protein; RP11-27J8.1;

IKBKB

inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta

IKBKB; IKK2; IKKB; NFKBIKB; FLJ33771; FLJ36218; FLJ38368; FLJ40509; IKK-beta; MGC131801; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta; inhibitor of nuclear factor kappa-B kinase subunit beta; IKK-B; I-kappa-B kinase 2; OTTHUMP00000225854; OTTHUMP00000225858; OTTHUMP00000225860; OTTHUMP00000225865; OTTHUMP00000225866; I-kappa-B-kinase beta; nuclear factor NF-kappa-B inhibitor kinase beta;

IKBKE

inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon

IKBKE; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon; inhibitor of nuclear factor kappa-B kinase subunit epsilon; IKK i; IKKE; KIAA0151; IKK-epsilon; I-kappa-B kinase epsilon; inducible IkappaB kinase; IKK-related kinase epsilon; inducible I kappa-B kinase; IKKI; IKK-E; IKK-i; MGC125294; MGC125295; MGC125297;

NFKB1

nuclear factor of kappa light polypeptide gene enhancer in B-cells 1

NFKB1; p50; KBF1; p105; EBP-1; MGC54151; NFKB-p50; NFkappaB; NF-kappaB; NFKB-p105; DKFZp686C01211; nuclearfactor NF-kappa-Bp105subunit; NF-kappabeta; OTTHUMP00000161765; OTTHUMP00000216418; OTTHUMP00000219572; DNA binding factor KBF1; nuclear factor NF-kappa-B p50 subunit; nuclear factor kappa-B DNA binding subunit;

NFKBIA

nuclear factor of kappa light polypeptide gene enhancer in B-cell extracts inhibitor, alpha

IKBA; MAD-3; NFKBI; I-kappa-B-alpha; IkappaBalpha; NF-kappa-B inhibitor alpha; ikB-alpha; major histocompatibility complex enhancer-binding protein MAD3; nuclear factor of kappa light chain gene enhancer in B-cells;

PAPPA

pregnancy-associated plasma protein A, pappalysin 1

PAPPA; pregnancy-associated plasma protein A, pappalysin 1; PAPA; DIPLA1; PAPP-A; PAPPA1; ASBABP2; IGFBP-4ase; pappalysin-1; IGF-dependent IGFBP-4 protease; aspecific BCL2 ARE-binding protein 2; pregnacy-associated plasma protein A; differentially placent;

PAPPA2

pappalysin 2

PAPPA2; pappalysin 2; PLAC3, placenta specific 3; pappalysin-2; PAPP A2; PAPPE; PAPP-E; placenta-specific 3; pregnancy-associated plasma protein E1; pregnancy-associated plasma preproprotein-A2; PLAC3; PAPP-A2;

POLK

polymerase (DNA directed) kappa

POLK; polymerase (DNA directed) kappa; DINB1; DNA polymerase kappa; DINB protein; DINP; POLQ;

NFKB2

nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)

NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100); nuclear factor NF-kappa-B p100 subunit; LYT 10; NF kB2; p52; p105; oncogene Lyt-10; DNA-binding factor KBF2; lymphocyte translocation chromosome 10 protein; nuclear fa;

NFKBIB

nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta

NFKBIB; IKBB; TRIP9; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta; NF-kappa-B inhibitor beta; ikB-B; TRIP-9; ikB-beta; ikappaBbeta; NF-kappa-BIB; I-kappa-B-beta; TR-interacting protein 9; thyroid receptor-interacting protein 9;

NFKBIE

nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon

NFKBIE; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon; NF-kappa-B inhibitor epsilon; IKBE; ikB-E; ikB-epsilon; NF-kappa-BIE; ikappaBepsilon; I-kappa-B-epsilon;

DCPS

decapping enzyme, scavenger

DCPS; decapping enzyme, scavenger; scavenger mRNA-decapping enzyme DcpS; HINT 5; HSL1; HSPC015; DCS-1; mRNA decapping enzyme; heat shock-like protein 1; histidine triad protein member 5; hint-related 7meGMP-directed hydrolase; homolog of C. elegans 7meGMP;

CAPZA2

capping protein (actin filament) muscle Z-line, alpha 2

CAPZA2; capping protein (actin filament) muscle Z-line, alpha 2; CAPZ; CAPPA2;

CAPZA3

Capping Protein (actin filament) Muscle Z-line, Alpha 3

CAPZA3; capping protein (actin filament) muscle Z-line, alpha 3; F-actin-capping protein subunit alpha-3; CP-alpha-3; CapZ alpha-3; germ cell-specific protein 3; F-actin capping protein alpha-3 subunit; CAPPA3; OTTHUMP00000239909; Gsg3; Capping Protein α3;

CAPZB

capping protein (actin filament) muscle Z-line, beta

CAPZB; capping protein (actin filament) muscle Z-line, beta; F-actin-capping protein subunit beta; capZ beta; CAPB; CAPZ; CAPPB; FLJ12274; FLJ44693; MGC104401; MGC129749; MGC129750; DKFZp686K0524;

CNO

cappuccino homolog (mouse)

CNO; cappuccino homolog (mouse); protein cappuccino homolog; BCAS4L; FLJ11230;

DCP1A

decapping mRNA 1A

DCP1A; decapping mRNA 1A; SMIF; SMAD4IP1; HSA275986; Nbla00360; mRNA-decapping enzyme 1A; decapping enzyme hDcp1a; transcription factor SMIF; DCP1 decapping enzyme homolog A; putative protein product of Nbla00360; Smad4-interacting transcriptional co-activator;

EDC3

enhancer of mRNA decapping 3 homolog (S. cerevisiae)

EDC3; enhancer of mRNA decapping 3 homolog (S. cerevisiae); LSM16, LSM16 homolog (EDC3, S. cerevisiae) , YJDC, yjeF domain containing (E.coli); enhancer of mRNA-decapping protein 3; FLJ21128; hYjeF_N2 15q23; YJEFN2; EDC 3; Enhancer of mRNA decapping 3 homolog; Enhancer of mRNA decapping protein 3; FLJ31777; LSM 16; LSM16; LSM16 homolog (EDC3 S. cerevisiae); LSM16 homolog; YJDC; YjeF domain containing; YjeF domain containing protein 1; yjeF_N2; hYjeF_N2; hYjeF_N2-15q23; OTTHUMP00000183472; yjeF domain-containing protein 1; LSM16 homolog (EDC3, S. cerevisiae); yjeF N-terminal domain-containing protein 2;

IKBKAP

inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein

inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein; IKBKAP; FD; DYS; ELP1; IKAP; IKI3; TOT1; FLJ12497; DKFZp781H1425; elongator complex protein 1; p150; OTTHUMP00000021869; IKK complex-associated protein; ikappaB kinase complex-associated protein;

IKBKG

IKBKG inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma

IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; incontinentia pigmenti , IP1, IP2; NF-kappa-B essential modulator; FIP 3; FIP3; Fip3p; IKK gamma; NEMO; IKKG; IKKAP1; incontinentia pigmenti; IkB kinase gamma subunit; ikB kinase subunit gamma; NFkappaB essential modulator; NF-kappa-B essential modifier; I-kappa-B kinase subunit gamma; ikB kinase-associated protein 1; inhibitor of nuclear factor kappa-B kinase subunit gamma; IP; IP1; IP2; IPD2; FIP-3; AMCBX1; IKK-gamma;

NUMA1

nuclear mitotic apparatus protein 1

NUMA; SP-H antigen; centrophilin stabilizes mitotic spindle in mitotic cells; structural nuclear protein;

RBPJ

recombination signal binding protein for immunoglobulin kappa J region

RBPJ; recombination signal binding protein for immunoglobulin kappa J region; SUH; csl; AOS3; CBF1; KBF2; RBP-J; RBPJK; IGKJRB; RBPSUH; IGKJRB1; recombining binding protein suppressor of hairless; CBF-1; RBP-JK; RBP-J kappa; H-2K binding factor-2; suppressor of hairless homolog; renal carcinoma antigen NY-REN-30; immunoglobulin kappa J region recombination signal binding protein 1;

NFKBIZ

nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta

NFKBIZ; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta; NF-kappa-B inhibitor zeta; FLJ34463; MAIL; ikB-zeta; ikappaBzeta; IkappaB-zeta; I-kappa-B-zeta; Ikappa B-zeta variant 3; IL-1 inducible nuclear ankyrin-repeat prot;

IGKC

immunoglobulin kappa constant

immunoglobulin light chain; Human Kappa Protein; Kappa Protein; IGKC; immunoglobulin kappa constant;

NFRKB

nuclear factor related to kappaB binding protein

NFRKB; nuclear factor related to kappaB binding protein; nuclear factor related to kappa-B-binding protein; DKFZp547B2013; DNA binding protein R kappa B; INO80 complex subunit G; INO80G; nuclear factor related to kappa B binding protein; DNA-binding prote;

EDC4

enhancer of mRNA decapping 4

EDC4; enhancer of mRNA decapping 4; enhancer of mRNA-decapping protein 4; Ge 1; HEDLS; RCD 8; autoantigen Ge-1; autoantigen RCD-8; human enhancer of decapping large subunit; Ge-1; RCD-8;

OPRK1

opioid receptor, kappa 1

OPRK1; K-OR-1; Kappa type opioid receptor; Kappa-type opioid receptor; KOR 1; KOR; KOR-1; Opiate receptor kappa 1; OPRK 1; OPRK; OPRK_HUMAN; Oprk2; R21; opioid receptor, kappa 1; OTTHUMP00000226313; Opioid Receptor, kappa; OTTHUMP00000226316; kappa opioid receptor; Opiate receptor, kappa-1;

IGKC2

immunoglobulin kappa constant 2

K-BAS; IGKC2; immunoglobulin kappa constant 2;

LOC500180

similar to IG KAPPA CHAIN V-V REGION K2 PRECURSOR

DACT3

dapper, antagonist of beta-catenin, homolog 3

DACT3; dapper, antagonist of beta-catenin, homolog 3 (Xenopus laevis); arginine rich region 1 , RRR1; dapper homolog 3; MGC15476; arginine rich region 1; arginine-rich region 1 protein; antagonist of beta-catenin Dapper homolog 3; RRR1;

CSN3

casein kappa

CSN3; casein kappa; casein, kappa , CSN10; kappa-casein; COP9 Signalosome Complex Subunit 3; COPS3; CSN10; JAB1 Containing Signalosome Subunit 3; SGN3; Signalosome Subunit 3; KCA; CSNK;

DACT2

dapper homolog 2, antagonist of beta-catenin (xenopus)

DACT2; dapper homolog 2, antagonist of beta-catenin (xenopus); Dpr2; Frd2; dapper2; A630024E20; 2900084M21Rik; dapper homolog 2; mDpr2; dapper antagonist of catenin 2; dapper, antagonist of beta-catenin, homolog 2;

DCP1B

DCP1 decapping enzyme homolog B (S. cerevisiae)

DCP1B; DCP1 decapping enzyme homolog B (S. cerevisiae); mRNA-decapping enzyme 1B; FLJ31638; DCP 1B; DCP1; DCP1 decapping enzyme homolog B; Decapping enzyme Dcp1b; Decapping enzyme hDcp1b; Decapping enzyme homolog B (S. cerevisiae); hDcp1b; mRNA decapping enzyme 1B;

DCP2

decapping mRNA 2

DCP2; decapping mRNA 2; NUDT20; m7GpppN-mRNA hydrolase; hDpc; mRNA-decapping enzyme 2; DCP2 decapping enzyme homolog; nudix (nucleoside diphosphate linked moiety X)-type motif 20;

DGKK

diacylglycerol kinase, kappa

DGKK; diacylglycerol kinase, kappa; diacylglycerol kinase kappa; 142 kDa diacylglycerol kinase; DAG kinase kappa; DGK kappa; Diglyceride kinase kappa; DGK-kappa;

TRE1

trapped in endoderm-1

TRE1; trapped in endoderm-1; CG3171 gene product from transcript CG3171-RA; CG3171-PA; Tre1-PA; scattershot; G protein coupled receptor; trapped in endoderm 1; anon-WO0170980.16; anon-WO0170980.17; anon-WO0170981.1; BEST:LD12308; CG3171; Dmel\CG3171; LD12308; sctt; tre-1;

MEPCE

methylphosphate capping enzyme

MEPCE; methylphosphate capping enzyme; BCDIN3, bin3, bicoid interacting 3, homolog (Drosophila); 7SK snRNA methylphosphate capping enzyme; FLJ20257; BCDIN3; Bicoid interacting protein 3 homolog; Bin3 bicoid interacting 3; Bin3 bicoid interacting 3 homolog (Drosophila); Bin3 bicoid interacting 3 homolog; Bin3 homolog; bin3, bicoid-interacting 3, homolog; bicoid-interacting protein 3 homolog;

NFKBIL1

nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1

NFKBIL1; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1; IKBL; LST1; NFKBIL; NF-kappa-B inhibitor-like protein 1; ikappaBL; I-kappa-B-like protein; inhibitor of kappa B-like protein;

NFKBID

nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta [ Homo sapiens

NFKBID;nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta;15671;ENSG00000167604;TA-NFKBH;IkappaBNS;19q13.12;MGC11314, MGC149503;NF-kappa-B inhibitor delta;NF-kappa-B inhibitor delta;ikB-delta;ikappaBdelta;I-kappa-B-delta;T-cell activation NFKB-like protein;

Leprotl1

leptin receptor overlapping transcript-like 1

LEPROTL1;leptin receptor overlapping transcript-like 1;ENSMUSG00000031513;AI854296;1110067H13Rik;1520402O14Rik;8 A4;8;leptin receptor overlapping transcript-like 1;leptin receptor overlapping transcript-like 1;

LEPROT

leptin receptor overlapping transcript

Obrgrp; Ob-Rgrp;

Bloc1s4

biogenesis of organelles complex-1, subunit 4, cappuccino

HYDIN

HYDIN, axonemal central pair apparatus protein

Rbpjl

recombination signal binding protein for immunoglobulin kappa J region-like

RBPJL; SUHL; RBPSUHL; recombination signal binding protein for immunoglobulin kappa J region-like; recombining binding protein suppressor of hairless-like protein; transcription factor RBP-L;

TEN1

TEN1 telomerase capping complex subunit

RGD1311078

TEN1 telomerase capping complex subunit

IGKV1-5

IGKV1-5?immunoglobulin kappa variable 1-5 [?Homo sapiens?(human) ]

V1; L12; IGKV; L12a; IGKV15; IGKV1-5; immunoglobulin kappa variable 1-5;

Protein Phosphorylation Site Identification and Mapping Service

Creative BioMart provides for the detection of phosphosites located in a target protein that has been phosphorylated in vivo and purified by immuno-precipitation or a recombinant protein that has been phosphorylated in vitro with a purified protein kinase. Our speciality is the identification of pr...

Epitope Mapping

Epitope mapping has become more and more vital in both vaccine and antibody drug development. Knowledge on epitope of an antibody will largely facilitate your drug design and patent application. Based on our advanced peptide library platform, Creative BioMart provides a comprehensive series of Epito...

Protein Binding Site Mapping

Understanding how proteins interact on a residue level is essential during the early stages of drug design and the later stages of lead optimization. It is equally important to identify the locations of any potential allosteric binding sites. This requires researchers to discover the location of pro...

How Gut Bacteria Impact On Your Appetites?

GI bacteria play a role in affecting hosts appetites In organism body, it is well known that beneficial bacteria are an essential part, so as the normal gastrointestinal (GI) bacteria. While these bacteria play other roles too, recently Vic Norris of the University of Rouen, France, and coauthor...

An Approved Malarial Drug is Promising for Preventing and Stopping Breast Cancer

Explore New Aspects from Old ItemsChloroquine During a clinical trial, researchers of Mason Center unexpectedly found a malarial drugChloroquine can stop the precursor cells of breast cancer, which brings hope and new thoughts for patients and doctors. Thus they launch a PINC (Preventing Invasiv...

Glybera became the first one that gets gene therapy approval

The first gene therapy for rare disease gets approval by European Commission This is an important news about gene therapy. After years of development and repeated rejections, uniQure finally got permission to market its gene therapyGlybera. Glybera was designed for certain patients with lipoprote...

Besides Cell Lines Culture, Lipid Storage etc., a New Application of Gene Plin2 was Found

Nowadays weight losing is very popular among women, even men. They adopt diet, exercise, medicine control etc. to achieve the result. But every coin has two sides and you need to pay something. On Lipid Research, a two-year study revealed an exciting finding that deleting a specific gene in m...

PNAS: Scientists Developed New Approach to Resolve Protein Structure

Recently scientists developed a new strategy that can be used to study protein structures that cant be realized previously. The new strategy combined computational modeling and experimental physicochemical techniques. The results were published on the journal of Proceedings of the Nat...

Nature Genetics: the Mapping of Telomerase was Disclosed for the First Time

Telomerase is an important enzyme that adds DNA sequence repeats to the 3 end of DNA strands in the telomere region. It is one of the fundamental enzymes in cell biology. It is a reverse transcriptase and shortened after every replication cycle. In 1970s, scientists have assumed that it was ...

Scientists Innovatively Modified an Approach to Dissect Kinases

The top is a structural model of uniRapR domain which binds small molecule rapamycin. The bottom left depicts inactive state of the protein of interest modified with uniRapR domain. Binding of rapamycin and uniRapR reactivates the protein (bottom right). The approach mentioned here i...

Epidermal Growth Factor Receptor and Its Applications

The discovery of growth factors won the Nobel Prize in Medicine in 1986, implying their importance. Epidermal growth factor receptor, EGFR, one of such factors, exists on cell surface and is activated by binding of its specific ligands. EGFR is a member of the receptor tyrosine kinase family who...

Industry Analysis: The Application and Development Trend of Recombinant Proteins

Recombinant proteins are manufactured by genetic engineering, cell engineering or other technologies, derived from organisms. Recombinant proteins have become one of the most products for current biology industry. From a broad range, recombinant proteins include recombinant proteins of na...

The Therapeutic Applications of Recombinant Interferons

Interferons are members of cytokines. They get the name after their ability to interfere with viral replication within host cells. They play vital functions in activating immune cells, recognition of infection or tumor cells, strengthening the ability of uninfected hot cells to resist new infection ...

Learn More about Epitope Mapping

Epitope mapping, a process of identifying the binding sites of antibodies on their target antigens, is more and more vital for the discovery and development of new therapeutics, vaccines and antibody drug development. Epitope can be divided into two categories that are linear and conformationa...

Biosimilar Market in India: the Approaching of the Expiration of Herceptin Patent in India

Roches patent on Herceptin will soon expire in India, thus today here we briefly talk about the biosimilar market in India regarding this. According to authority information, there is still no clear trend if the local pharmaceuticals start to march to biosimilar market. ...

2013 Conference in Applied Bioinformatics & Public Health Microbiology

When May 15, 2013 to May 17, 2013 Where Moller Centre, Churchill College, Cambridge, UK Introduction Till now, the conference registration and abstract submission has closed. But the conference indeed accepts waitlist. Organized by Wellcome Trust, the conference aims to recent ...

The New Diabetes Drug of Novo Nordisk A/S (NVO) Get Approval by FDA

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. On Nov. 8, 2012, the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) completed the New Drug Application (NDA) for insulin degludec...

The Last FDA Approvals in 2012 for World Pharma Regulatory Blockbusters (From Dec. 21 to Dec. 31)

On Dec. 31, 2012, the last day of the year, the FDA came through with a rapid-fire approval of Johnson Johnson's bedaquiline, the first new treatment for drug-resistant tuberculosis in four decades. The approval was based on mid-stage data after JJ ($JNJ) made its case that the urgent nee...

The FDA Approval of Flublok

On Jan. 16, 2013, the U.S. Food and Drug Administration (FDA) announced the approval of Flublok for the prevention of seasonal influenza in people aged from 18 to 49. Flublok is the first trivalent influenza vaccine that uses baculovirus expression system and novel recombinant DNA technology. The t...

The Worldwide Biotech’s Approval or Restricting by FDA (From Feb. 15 to Feb. 22)

On Feb 22, 2013, Roche's ($RHHBY) Genentechpicked up FDA approval for its late-stage breast cancer therapy Kadcyla, formerly T-DM1, which uses antibodies to deliver cancer drugs directly to the offending cells. The treatment combinesImmunoGen's ($IMGN)taxane chemotherapy drug, DM1, with an ant...

Merry Christmas and Happy New Year

Holiday Sale Hi everyone! Looking for great holiday gifts at a killer price? The holiday season is officially upon us, and were helping you treat yourself with three weeks of deals on Creative BioMart. We've got holiday deals that will bring you amazing savings on protein products and services. B...

Merry Christmas and Happy New Year 2017

Merry Christmas and Happy New Year！ We would like to take the opportunity during the holiday season to express our sincere gratitude for you as our cherished customer. None of our achievements would have been possible without you and your unwavering support. May our professional relationship st...

Merry Christmas and Happy New Year

Merry Christmas and Happy New Year！ A sincere thanks to you for showing full faith in us and believing in us. We value our relationship, in which we achieved so much. In the coming year, we will strive to strengthen this bond even more. From the entire team at Creative BioMart, we wish yo...

Merry Christmas and Happy New Year

Merry Christmas and Happy New Year！ Its in the spirit of the holiday that we extend our huge thanks to cherished customer like you. Thanks for being so patient and supportive. And we will endeavor to exceed your expectations in the coming year. May your Christmas season be filled with peac...